Last reviewed · How we verify

IPTi — Competitive Intelligence Brief

IPTi (IPTi) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimalarial preventive strategy. Area: Infectious Disease / Parasitology.

phase 3 Antimalarial preventive strategy Infectious Disease / Parasitology Small molecule Live · refreshed every 30 min

Target snapshot

IPTi (IPTi) — Swiss Tropical & Public Health Institute. IPTi (Intermittent Preventive Treatment in infants) is a malaria prevention strategy that administers antimalarial drugs at scheduled intervals to infants to prevent malaria infection and disease.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
IPTi TARGET IPTi Swiss Tropical & Public Health Institute phase 3 Antimalarial preventive strategy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimalarial preventive strategy class)

  1. Swiss Tropical & Public Health Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IPTi — Competitive Intelligence Brief. https://druglandscape.com/ci/ipti. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: